Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

New Angioplasty System Dilates Calcified & Fibrotic Vessels

November 12, 2020
By Transit Scientific
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

PARK CITY, Utah, Nov. 12, 2020 /PRNewswire/ — The new FDA cleared XO Score® system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at Tri City Medical Center Medical Center, Oceanside, California, USA performed the first procedures using the XO Score. Treatment of all the lesions proved successful.

“The XO device performed well and demonstrated effective lesion dilatation at low pressures with a variety of our standard angioplasty balloons,” said Richard Saxon, MD. “The rotating scoring struts appeared to be effective against a mix of fibrous and calcified lesions which tend to be highly resistant to plain old angioplasty.”

Percutaneous transluminal angioplasty (PTA) balloons are used millions of times-per-year to dilate narrowed, or stenosed, arteries and veins.  Hospitals typically stock hundreds of different angioplasty balloons diameters and lengths to cover diverse patient needs.  Calcified and/or fibrous vessels are difficult to dilate and often require high-pressure and/or scoring & cutting systems. 

Specialty scoring & cutting angioplasty balloons are manufactured with integrated struts, wires, or blades to reduce vessel dissection, dilation pressure, and assist with vessel preparation for atherectomy and/or stenting.  However, scoring & cutting balloons also add profile, bulk, expense, inventory, and complexity.   

The FDA-Cleared XO Score is different.  XO Score technology allows users to convert basic angioplasty balloons in the hospital’s existing inventory into sophisticated scoring, cutting, and infusion/delivery devices. 

“One of the procedures required five separate inflations at various points along the native fistula and outflow vein, all of which were accomplished using the same XO Score device,” continued Dr. Saxon. “The ability to achieve a more predictable result at a lower and potentially safer pressure in resistant lesions could prove important in achieving the best possible PTA outcomes and thereby help in fistula maintenance. The fact that you can take quick angiograms through the XO Score and around the PTA balloon was a nice additional feature.”

During an XO Score procedure, clinicians insert a basic angioplasty balloon into the ultra-thin XO Score sheath and advance the combined balloon and XO Sheath to the stenosis.  When the balloon is inflated, up to 22 evenly spaced XO Score struts expand with the balloon and rotate 900 to score & cut the narrowed vessel.  When the balloon is deflated, the struts rotate 900 back to an atraumatic position to assist balloon rewrap and removal.

“We are thrilled to see the XO Score contribute to patient care,” said Greg Method, President & CEO of Transit Scientific. “These procedures demonstrate XO Score effectiveness against a variety of lesion types.  We look forward to growing the platform to treat complex peripheral arterial disease (PAD), critical limb ischemia (CLI), along with hemodialysis access patients.” 

The XO Score system is FDA cleared to dilate stenotic material in iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistula.    

Transit Scientific designs, develops, and commercializes medical devices including the FDA-cleared XO Score® scoring sheath and  XO Cross® microcatheters.  XO Cross 014 and 035 microcatheters were launched Fall 2020.  The XO Score and XO Cross platform is protected by 25+ combined issued and pending global patents.   www.XOScore.com

Transit Scientific Media contact:  Jennifer Arnold (412) 496-3609, info@XOScore.com.

 

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

Simple History Article Test 5/26/26

9:40 Future Import Test - Edited

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
X